Hatteras Venture Partners

Hatteras Venture Partners

Founded in 2000 by Clay Thorp and John Crumpler, Hatteras Venture Partners operates from Durham, North Carolina, embedding itself in the Research Triangle ecosystem that spans Duke University, University of North Carolina, and North Carolina State. The firm grew alongside the region's emergence as a credible biotech hub, cultivating relationships with academic spinouts and serial entrepreneurs in life sciences. The firm targets seed and early-stage investments across human health, with a portfolio concentrated in biotechnology, medical devices, and healthcare services. Sectors of activity include drug development platforms, diagnostic tools, and health IT. Hatteras makes both initial equity investments and follow-on commitments, typically leading or co-leading rounds for companies originating in the Research Triangle and broader southeastern United States. Representative portfolio holdings have included pharmaceutical, medtech, and health-service companies built around university-licensed intellectual property. The firm invests primarily in equity, deploying through discrete fund vintages. Hatteras Venture Partners has executed multiple fundraises since inception, anchoring its position as one of the largest dedicated life-science venture firms in the southeastern United States. The firm maintains its operations from its Durham headquarters and has not disclosed additional office locations. Team members hold deep scientific and operational backgrounds, often with prior experience in pharma research or clinical medicine. In recent years, Hatteras has continued to invest from its latest active fund, supporting preclinical and clinical-stage companies. (Specific fund names and sizes are not publicly disclosed.) A structural differentiator for Hatteras is its fundamental tie to the Research Triangle's academic research base, granting it preferential access to deal flow originating from faculty- and student-founded ventures that often lack visibility among coastal venture firms. The firm's two-decade presence in a concentrated geography creates a sourcing advantage not easily replicated by generalist or visiting investors.